Literature DB >> 2569760

NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes.

L Fugger1, N Morling, L P Ryder, P Platz, J Georgsen, B K Jakobsen, A Svejgaard, K Dalhoff, L Ranek.   

Abstract

The restriction fragment length polymorphism of the human tumour necrosis factor (TNF alpha) region was investigated by means of 20 different restriction enzymes and a human TNF alpha cDNA probe. Only one of the enzymes, NcoI, revealed a polymorphic pattern consisting of fragments of 10.5 and 5.5 kb, which behaved as alleles. In a panel of 108 random, healthy, unrelated Danes, the phenotype frequencies of the 10.5 and 5.5 kb bands were 0.94 and 0.53 and the gene frequencies were 0.71 and 0.29, respectively. The test for Hardy-Weinberg equilibrium showed no significant deviation from the expected values. The 5.5 kb band was strongly positively associated with HLA-DR3, HLA-B8, and HLA-A1. In 22 patients with primary biliary cirrhosis a significantly (corrected P = 0.024) decreased frequency of the 10.5 kb fragment was found. Additional studies are in progress to substantiate this association.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569760     DOI: 10.1111/j.1365-3083.1989.tb01200.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Haplotypic polymorphisms of the TNFB gene.

Authors:  L J Abraham; D C Du; K Zahedi; R L Dawkins; A S Whitehead
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 2.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Relation of a TNF gene polymorphism to severe sepsis in trauma patients.

Authors:  M Majetschak; S Flohé; U Obertacke; J Schröder; K Staubach; D Nast-Kolb; F U Schade; F Stüber
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.

Authors:  S J Greenberg; K Fujihara; S M Selkirk; F Yu; T L Du; N Glenister; P Hohmann; M H Rickert; P O Spence; C E Miller; L D Jacobs
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 5.  Prevalence and pattern of familial disease in primary biliary cirrhosis.

Authors:  A M Brind; G P Bray; B C Portmann; R Williams
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

6.  Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility.

Authors:  T Yoshikawa; J W Streilein
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis.

Authors:  G M Verjans; B M Brinkman; C E Van Doornik; A Kijlstra; C L Verweij
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes.

Authors:  C V Jongeneel; L Briant; I A Udalova; A Sevin; S A Nedospasov; A Cambon-Thomsen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  DNA polymorphism of HLA class II genes in primary biliary cirrhosis.

Authors:  N Morling; K Dalhoff; L Fugger; J Georgsen; B Jakobsen; L Ranek; N Odum; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.

Authors:  M Cabrera; M A Shaw; C Sharples; H Williams; M Castes; J Convit; J M Blackwell
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.